Diagnosis is much easier with ‘smart biopsy’ method MR TRUS Fusion in prostate cancer

Prostate cancer is the most common cancer in men and the second most common cancer in the world. According to the data of the World Health Organization, while approximately 1.1 million people are diagnosed with prostate cancer in the world, this rate corresponds to approximately 12.500 new patients in Turkey. Referring to the importance of early diagnosis in prostate cancer as in all cancer types, Urology Specialist Prof. Dr. Cemil Uygur shares the following information on the subject: “Prostate cancer is increasing day by day, but new diagnostic methods such as MR TRUS Fusion biopsy also make us smile. This is an effortless method for the patient. With MR TRUS Fusion technology, the biopsy process is not repeated several times, the tumor is detected and displayed in 3D, and a biopsy is taken in one go. With a more accurate and precise diagnosis, treatment is planned much faster.”

According to the data of the World Health Organization, the incidence of cancer has increased by 11 percent in the last 4 years, reaching 14 million new cases annually. While the figures show that cancer causes the death of 8.2 million patients every year, early diagnosis is of great importance in saving the lives of patients. In order to draw attention to this important health problem and increase the awareness of the society about cancer, the fight against cancer aims to keep awareness alive as part of the 4th February World Cancer Day.

Early diagnosis is important in prostate cancer

Pay attention to pain or burning sensation when urinating

Prostate cancer does not give any symptoms in the early stages. Prostate cancer is one of the important health problems affecting the male society today. This disease is the cause of approximately 9 percent of cancer-related deaths in men. Over time, the growth of cancerous tissue and pressure on the urethra (urinary tract) passing through the prostate can cause problems with urination.

In general, complaints that occur in this late period may be in the form of increased urinary frequency, weakening of the urine stream, inability to urinate, intermittent urination, pain/burning sensation during urination, and blood in the urine. If the disease has spread to bones other than the prostate, bone pain may occur, especially in the back region, hips, legs and ribs.

Diagnosis is made much faster with the new method

Men over the age of 45 who have a family member diagnosed with prostate cancer and over the age of 50 without a family history of prostate cancer have a risk of developing prostate cancer at any time in their lives. Although it can be seen at earlier ages, the risk of cancer increases in parallel with advancing age. In addition, the presence of prostate cancer in first-degree relatives, such as a father or brother, increases the risk of cancer in that person.

In addition, some studies show that a diet rich in fat increases the risk of prostate cancer. Every man with a life expectancy of more than 10 years should have a prostate examination and serum PSA level control once a year from the age of 50.

Annual PSA test against prostate cancer saves lives

Targeted Prostate MR-TRUS Fusion Biopsy is a method that uses advanced technology device and software to detect cancer-suspicious foci in the prostate and to perform biopsy from these foci with millimetric precision. MR-TRUS Fusion is a ‘smart biopsy’ method with high accuracy and sensitivity in the diagnosis of prostate cancer.

This method is based on processing the Magnetic Resonance (MR) images of the prostate with the help of a special software and combining them with the real-time Trans Rectal Ultrasonography (TRUS) image. Thanks to the method, cancer foci can be detected with higher accuracy by imaging in 3D, and there is no need for repetitive biopsies.

In early diagnosis, life expectancy is no different from cancer-free patients.

The life expectancy of patients who are diagnosed at an early stage and treated appropriately is the same as those without cancer. Surgical treatment is the primary option for many patients diagnosed at an early stage. In the surgical method called radical prostatectomy, the prostate gland is removed as a whole along with the seminal sacs. Radiotherapy (Radiation therapy), another treatment method, is a treatment method that can be used when the cancer is confined to the prostate.

It can also be used in case of regional spread of prostate cancer. Radiotherapy can be in the form of targeted irradiation of the cancerous area from outside the body, or it can be applied by placing radioactive nucleoli directly into the cancerous area or in some people using both methods together.

Prostate cancer symptoms, early diagnosis and new treatment options

Very successful results can be obtained in the treatment of organ-confined prostate cancer with both surgery and radiation therapy. Your doctor will give you detailed information about which treatment option is most suitable for you. Hormonal therapy is also used in patients with involvement of other parts of the body. Basically, it can be applied in the form of drug use and surgically providing the effect created by drugs.

In the advanced period, when the disease becomes unresponsive to hormonal therapy, chemotherapy is used for treatment. One of the important points that should not be forgotten is that the contact with the doctor should not be interrupted after the appropriate treatment has started. In the follow-ups, the doctor can make changes in the treatment about the course of the disease, in line with the results, by performing an examination and serum PSA control. There is nothing specific to do for protection. Since it is more common in people who eat only excess fat, eating a fat-free diet can be a method of protection.




Inline Feedback
See all reviews

Hi, I'm Alex Huynh, an expert in the field of mesothelioma. I have worked in this field for more than 10 years. With my experience and knowledge in this field, I decided to set up a website mesothelioma media to help people treat mesothelioma.

We will be happy to hear your thoughts

Leave a reply

Mesothelioma Media